VBI Vaccines Inc/BC Annual Interest Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
VBI Vaccines Inc/BC quarterly/annual Interest Expense history and growth rate from 2015 to 2023.
  • VBI Vaccines Inc/BC Interest Expense for the quarter ending March 31, 2024 was $1.82M, a 27.2% increase year-over-year.
  • VBI Vaccines Inc/BC Interest Expense for the twelve months ending March 31, 2024 was $6.79M, a 51% increase year-over-year.
  • VBI Vaccines Inc/BC annual Interest Expense for 2023 was $6.4M, a 59.7% increase from 2022.
  • VBI Vaccines Inc/BC annual Interest Expense for 2022 was $4.01M, a 15.3% decline from 2021.
  • VBI Vaccines Inc/BC annual Interest Expense for 2021 was $4.73M, a 74.7% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.4M +$2.39M +59.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $4.01M -$725K -15.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $4.73M +$2.02M +74.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-13
2020 $2.71M +$512K +23.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-07
2019 $2.2M -$436K -16.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $2.63M -$250K -8.68% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $2.88M +$2.56M +790% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-25
2016 $324K -$781K -70.7% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-20
2015 $1.11M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.